$11.350
-0.961 (-8.47%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABCL Prediction & Forecast by Similar Chart Analysis
Alphio's ABCL stock price prediction model matches the current AbCellera Biologics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.35 (+0.01%). The 1-week path is $12.00 (+5.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy AbCellera Biologics Inc. Stock?
Abcellera Biologics Inc is a good buy right now, as it has shown a remarkable year-to-date change of +230.90% and a current price of $11.35, which is below the analyst price target of $30 from Truist. The stock's RSI is at 51.378, indicating it is neither overbought nor oversold, which suggests a balanced entry point. However, the main risk is its negative earnings per share (EPS) of -0.18 reported for Q2 2026, indicating ongoing losses.
ABCL stock price ended at $11.35 on Friday, after losing -8.47%
AbCellera Biologics Inc. (ABCL) last closed at $11.35, losing -8.47%. These facts feed the 1-day and 1-week ABCL price prediction above.
Forecast Drivers
AbCellera Biologics Inc. (ABCL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABCL, ranked by similarity.
Seasonality analysis for ABCL
Historically the probability of a positive August return for ABCL is 65.08%. July offers the highest probability of a positive month at 66.67%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABCL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.24 | $1.91 | $2.25 | -83.16% |
| Sep 2026 | $0.96 | $1.74 | $2.10 | -84.70% |
| Oct 2026 | $1.11 | $1.60 | $1.84 | -85.86% |
| Nov 2026 | $2.00 | $2.06 | $2.54 | -81.83% |
| Dec 2026 | $1.71 | $1.76 | $2.25 | -84.50% |
In 2026, AbCellera Biologics Inc. (ABCL) is projected to range from $0.96 to $2.54.
AbCellera Biologics Inc. 2026 monthly forecast
In Aug 2026, AbCellera Biologics Inc. is projected to average $1.91, with a low of $1.24 and high of $2.25.
In Sep 2026, AbCellera Biologics Inc. is projected to average $1.74, with a low of $0.96 and high of $2.10.
In Oct 2026, AbCellera Biologics Inc. is projected to average $1.60, with a low of $1.11 and high of $1.84.
In Nov 2026, AbCellera Biologics Inc. is projected to average $2.06, with a low of $2.00 and high of $2.54.
In Dec 2026, AbCellera Biologics Inc. is projected to average $1.76, with a low of $1.71 and high of $2.25.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。